Vir Biotechnology
VIR
VIR
219 hedge funds and large institutions have $1.68B invested in Vir Biotechnology in 2022 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 94 increasing their positions, 53 reducing their positions, and 30 closing their positions.
Holders
219
Holders Change
+9
Holders Change %
+4.29%
% of All Funds
3.79%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.07%
New
39
Increased
94
Reduced
53
Closed
30
Calls
$5.6M
Puts
$5.18M
Net Calls
+$429K
Net Calls Change
-$4.47M
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$191M |
| 2 |
2
BlackRock
New York
|
$267M |
| 3 |
3
Renaissance Technologies
New York
|
$29.2M |
| 4 |
4
Temasek Holdings
Singapore
|
$116M |
| 5 |
5
American Century Companies
Kansas City,
Missouri
|
$10.8M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
251
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|
|
CM
252
Caption Management
Oklahoma City,
Oklahoma
| – | – | – | – |
|
|
CA
253
Clearstead Advisors
Cleveland,
Ohio
| $0 | 20 | – | – |
|
|
BTI
254
Blue Trust Inc
Alpharetta,
Georgia
| $0 | 10 | +10 | New |
|